Company / Capital Expenditures
RxSight, Inc. Capital Expenditures History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$4.8M
FY2025
5-year range
$1.9M / $4.8M
FY2021-FY2025
Trend
+101.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $2M to $5M over the past 2 years.
Based on SEC 10-K filings.
$5M in FY2025 with a 3-year CAGR of +35.4%.
Improved from $2M to $5M over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +35.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +35.4%, indicating consistent growth.
- In FY2025, capital expenditures increased 101.2% year-over-year.
- Lowest capital expenditures in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.59 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.8M | +101.2% |
| FY2024 | $2.4M | +0.0% |
| FY2023 | $2.4M | +23.4% |
| FY2022 | $1.9M | -23.6% |
| FY2021 | $2.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026